Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;260(8):2033-41.
doi: 10.1007/s00415-013-6931-1. Epub 2013 Apr 30.

Clinical phenotype, muscle MRI and muscle pathology of LGMD1F

Affiliations

Clinical phenotype, muscle MRI and muscle pathology of LGMD1F

Enrico Peterle et al. J Neurol. 2013 Aug.

Abstract

Of the seven autosomal dominant genetically distinct forms of LGMD so far described, in only four the causative gene has been identified (LGMD1A-1D). We describe clinical, histopathological and muscle MRI features of a large Italo-Spanish kindred with LGMD1F presenting proximal-limb and axial muscle weakness. We obtained complete clinical data and graded the progression of the disease in 29 patients. Muscle MRI was performed in seven patients. Three muscle biopsies from two patients were investigated. Patients with age at onset in the early teens, had a more severe phenotype with a rapid disease course; adult onset patients presented a slow course. Muscle MRI showed prominent atrophy of lower limb muscles, involving especially the vastus lateralis. Widening the patients population resulted in the identification of previously unreported features, including dysphagia, arachnodactyly and respiratory insufficiency. Muscle biopsies showed diffuse fibre atrophy, which evolved with time, chronic myopathic changes, basophilic cytoplasmic areas, autophagosomes and accumulation of myofibrillar and cytoskeletal proteins. The LGMD1F is characterized by a selective involvement of limb muscles with respiratory impairment in advanced stages, and by different degrees of clinical progression. Novel clinical features emerged from the investigation of additional patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neuropathology. 2013 Jun;33(3):276-80 - PubMed
    1. Neuromuscul Disord. 2011 May;21(5):338-44 - PubMed
    1. Nat Genet. 2012 Feb 26;44(4):450-5, S1-2 - PubMed
    1. Eur J Hum Genet. 2010 Jun;18(6):636-41 - PubMed
    1. Am J Hum Genet. 1997 Apr;60(4):891-5 - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources